Point mutations and genomic deletions in CCND1 create stable truncated cyclin D1 mRNAs that are associated with increased proliferation rate and shorter survival
Top Cited Papers
Open Access
- 1 June 2007
- journal article
- Published by American Society of Hematology in Blood
- Vol. 109 (11) , 4599-4606
- https://doi.org/10.1182/blood-2006-08-039859
Abstract
A gene expression signature of tumor proliferation rate in mantle cell lymphoma (MCL) is an overriding molecular predictor of the length of survival following diagnosis. Many strongly proliferative MCL tumors have exceptionally high cyclin D1 mRNA levels and preferentially express short cyclin D1 mRNA isoforms. We demonstrate here that these short mRNAs are cyclin D1a isoforms with truncated 3′UTRs, not alternatively spliced cyclin D1b mRNA isoforms. Among 15 MCL tumors with truncated cyclin D1 mRNAs, 7 had genomic deletions in the CCND1 3′UTR region. In 3 others, CCND1 contained point mutations that created premature polyadenylation signals, giving rise to 1.5-kb mRNAs lacking most of the 3′UTR. Both types of genomic alteration created transcripts lacking mRNA destabilization elements present in the wild-type cyclin D1a mRNA. Premature polyadenylation due to a 3′UTR mutation also was present in the Z-138 MCL cell line, which expressed both truncated and full-length cyclin D1a mRNAs. In these cells, the half-life of the short cyclin D1a mRNA was much longer than that of the full-length mRNA. We conclude that alterations of CCND1 3′UTR structure can significantly increase its oncogenic effect and worsen the clinical course of MCL patients.Keywords
This publication has 49 references indexed in Scilit:
- Cyclin D1: polymorphism, aberrant splicing and cancer riskOncogene, 2006
- The Widespread Impact of Mammalian MicroRNAs on mRNA Repression and EvolutionScience, 2005
- Phase II Trial of Single-Agent Temsirolimus (CCI-779) for Relapsed Mantle Cell LymphomaJournal of Clinical Oncology, 2005
- Combinatorial microRNA target predictionsNature Genetics, 2005
- Systematic discovery of regulatory motifs in human promoters and 3′ UTRs by comparison of several mammalsNature, 2005
- Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAsNature, 2005
- A small deletion in the 3′-untranslated region of the cyclin D1/PRAD1/bcl-1 oncogene in a patient with chronic lymphocytic leukemiaInternational Journal of Cancer, 1998
- Cyclin D1 (PRAD1) alternative transcript b: full-length cDNA cloning and expression in breast cancersCancer Letters, 1997
- Absence of cyclin D1/PRAD1 point mutations in human breast cancers and parathyroid adenomas and identification of a new cyclin D1 gene polymorphismCancer Letters, 1995
- Cyclosporin A inhibits growth of autocrine tumour cell lines by destabilizing interleukin-3 mRNANature, 1994